Inhibition of Pathogenic Mutant SOD1 Aggregation in Cultured Motor Neuronal Cells by Prevention of Its SUMOylation on Lysine 75
暂无分享,去创建一个
R. Uzbekov | P. Vourc'h | C. Andres | P. Corcia | S. Marouillat | C. Arnoult | C. Veyrat-Durebex | H. Blasco | A. Dangoumau | Julien Burlaud Gaillard
[1] T. Niikura,et al. SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants , 2014, PloS one.
[2] J. Pouget,et al. A novel SOD1 mutation p.V31A identified with a slowly progressive form of amyotrophic lateral sclerosis , 2014, Neurobiology of Aging.
[3] B. Kalmar,et al. Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis , 2013, PloS one.
[4] Jaclyn R. Gareau,et al. SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation , 2013, Cell reports.
[5] Jochen H Weishaupt,et al. Sumoylation in neurodegenerative diseases , 2013, Cellular and Molecular Life Sciences.
[6] J. Henley,et al. SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor Surface Expression (ChemLTP) in Hippocampal Neurons , 2013, PloS one.
[7] P. Vourc'h,et al. Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis , 2013, The International journal of neuroscience.
[8] Ammar Al-Chalabi,et al. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.
[9] J. Lachuer,et al. Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis‐linked mutant SOD1 cultured neurons , 2011, Journal of neuroscience research.
[10] K. Chung,et al. Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation , 2011, Journal of the Neurological Sciences.
[11] Jaclyn R. Gareau,et al. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition , 2010, Nature Reviews Molecular Cell Biology.
[12] A. Levey,et al. Multiplex SILAC Analysis of a Cellular TDP-43 Proteinopathy Model Reveals Protein Inclusions Associated with SUMOylation and Diverse Polyubiquitin Chains* , 2010, Molecular & Cellular Proteomics.
[13] J. Iñiguez-Lluhí,et al. Small Ubiquitin-like Modifier (SUMO) Modification of the Androgen Receptor Attenuates Polyglutamine-mediated Aggregation*♦ , 2009, The Journal of Biological Chemistry.
[14] S. Jentsch,et al. Principles of ubiquitin and SUMO modifications in DNA repair , 2009, Nature.
[15] P. Riso,et al. Mutation of SOD1 in ALS: a gain of a loss of function. , 2007, Human molecular genetics.
[16] P. Fraser,et al. SUMO on the road to neurodegeneration. , 2007, Biochimica et biophysica acta.
[17] V. Kirkin,et al. Role of ubiquitin- and Ubl-binding proteins in cell signaling. , 2007, Current opinion in cell biology.
[18] X. Yao,et al. SUMO-1 modification increases human SOD1 stability and aggregation , 2006, Neuroscience Research.
[19] Fujian Zhang,et al. Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. , 2006, Biochimica et biophysica acta.
[20] Torsten Schwede,et al. BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .
[21] P. Andersen,et al. Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes , 2006, Neuroscience Letters.
[22] M. Baptista,et al. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. , 2005, Brain : a journal of neurology.
[23] J. Rothstein,et al. Aggregate Formation in Cu,Zn Superoxide Dismutase-related Proteins* , 2003, The Journal of Biological Chemistry.
[24] K. Fischbeck,et al. Toxic Proteins in Neurodegenerative Disease , 2002, Science.
[25] Robert H. Brown,et al. Familial Amyotrophic Lateral Sclerosis-associated Mutations Decrease the Thermal Stability of Distinctly Metallated Species of Human Copper/Zinc Superoxide Dismutase* , 2002, The Journal of Biological Chemistry.
[26] D. Price,et al. Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues , 2001, Neurobiology of Disease.
[27] L. Bruijn,et al. Toxicity of ALS-linked SOD1 mutants. , 2000, Science.
[28] A. Wernimont,et al. Crystal structure of the copper chaperone for superoxide dismutase , 1999, Nature Structural Biology.
[29] L. Bruijn,et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.
[30] M. Beal,et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.
[31] M. Pericak-Vance,et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.
[32] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[33] M. Gurney,et al. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase. , 1996, Pathologie-biologie.